This entry was posted in nosocomial pregnancy week by week infections, MRSA, with the word (s) key

Syntiron, an American pharmaceutical company, announced in December 2009 an agreement pregnancy week by week with the company Sanofi-Aventis for a worldwide license for the exploitation of its human vaccine. Staphylococcus aureus resistant to methicillin pregnancy week by week (MRSA or) is a hospital-acquired infectiion (or nosocomial infection) that causes pregnancy week by week significant 18,000 deaths per year in the United States and 500,000 hospitalizations, for a total cost of 3.4 billion dollars to the U.S. health care system each year.
Syntiron owns the licensing rights to commercialize human applications Epitopix technology that is already used for the production of vaccines in animals. These vaccines pregnancy week by week have been proven safe and effective against a variety of bacterial infections in animals. They are approved and used in cattle for prevention of Salmonella and E. coli.
This entry was posted in nosocomial pregnancy week by week infections, MRSA, with the word (s) key (s) nosocomial pregnancy week by week infections, pregnancy week by week infection, MRSA vaccine. You can Bookmark the permalink.
You can use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <blockquote cite=""> <b> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>